Clinical and etiological aspects of movement disorders in a low-income country: Case of Mali
Objective: Describing Clinical and etiological aspects of movement disorders in Mali Background: Movement disorders (MD) correspond to a disturbance in the programming and / or…Development of a time-to-event endpoint for use in premanifest Huntington’s disease (HD) clinical trials
Objective: To develop and evaluate a time-to-event endpoint to measure disease progression in individuals with premanifest HD. Background: HD is typically diagnosed between the ages…Implementation of an online, interactive curriculum in movement disorders at nine neurology residency programs
Objective: Determine knowledge growth and resident satisfaction with an online curriculum in movement disorders across multiple programs. Background: Exposure to movement disorders in residency is…How Well Does the Composite Unified Huntington’s Disease Rating Scale (cUHDRS) Reflect Disease Progression in Huntington’s disease (HD)?
Objective: To examine the usefulness of the cUHDRS in reflecting disease progression in a well-characterized group of mild to moderate HD subjects followed at one…Sleep and Polysomnographic Abnormalities in Indian Patients with Huntington’s Disease
Objective: To study the sleep abnormalities in patients with HD by usingquestionnaire and Video Polysomnography (VPSG) and correlate with the eye movement abnormalities. Background: About 87.8% of the patients report some sleep disturbance…Speech is a sensitive marker in premanifest Huntington’s disease: exploring acoustic, cognitive and fine motor performance
Objective: To explore the utility of objective analysis of speech as a quantifiable clinical biomarker in premanifest HD. Background: The autosomal dominant inheritance of Huntington’s…Huntington’s Disease in Israel – 20 years of follow up from Maccabi Healthcare Services
Objective: To describe Huntington’s Disease (HD) epidemiology in Israel and depict comorbidities and longitudinal healthcare resources utilization. Background: HD is a rare, inherited neurodegenerative disorder,…Remote and frequent assessment of Huntington’s disease in clinical trials: Strategies for assessing and accounting for the practice effect
Objective: To assess the impact of task repetition on performance in digital assessments on Huntington’s disease (HD) and establish the number of practice test iterations…HD Constellation: A novel patient-centred approach to enriching clinical datasets by combining medical record chart review and Enroll-HD
Objective: HD Constellation aims to create a dataset providing a longitudinal view of the Huntington’s disease (HD) course, based on physician-provided medical records in the…Biological and Clinical Manifestations of Huntington’s disease in Gene Carriers Very Far from Predicted Onset: The Young Adult Study
Objective: To perform a deep phenotyping of a Huntington’s Disease (HD) cohort further from onset than previously studied to establish when disease related markers first…
- « Previous Page
- 1
- …
- 11
- 12
- 13
- 14
- 15
- …
- 20
- Next Page »